These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
611 related articles for article (PubMed ID: 15329282)
1. [Dendritic cells present particulate E7 protein of human papillomavirus and induce strong immunity]. Li J; Gao HQ; Zhao CL; Li LZ; Ji CY; Hou M; Plebaski M Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):932-6. PubMed ID: 15329282 [TBL] [Abstract][Full Text] [Related]
2. [Allogeneic dendritic cell vaccine pulsed with heat shocked tumor cell lysate can enhance antitumor immunity]. You J; Wang CL; Hao XS Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2785-90. PubMed ID: 18167273 [TBL] [Abstract][Full Text] [Related]
3. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen. Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645 [TBL] [Abstract][Full Text] [Related]
4. HPV16E7 tumor antigen modified by KDEL sequence induce specific cytotoxic T lymphocytes-dependent antitumor immunity. Yin R; Zheng W; Hao F; Yang XC; Zhong BY; Li QJ J Dermatol Sci; 2009 Aug; 55(2):116-22. PubMed ID: 19500947 [TBL] [Abstract][Full Text] [Related]
5. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus. Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665 [TBL] [Abstract][Full Text] [Related]
6. Adenoviral vectors targeted to CD40 enhance the efficacy of dendritic cell-based vaccination against human papillomavirus 16-induced tumor cells in a murine model. Tillman BW; Hayes TL; DeGruijl TD; Douglas JT; Curiel DT Cancer Res; 2000 Oct; 60(19):5456-63. PubMed ID: 11034088 [TBL] [Abstract][Full Text] [Related]
7. Strategies for antigen choice and priming of dendritic cells influence the polarization and efficacy of antitumor T-cell responses in dendritic cell-based cancer vaccination. Galea-Lauri J; Wells JW; Darling D; Harrison P; Farzaneh F Cancer Immunol Immunother; 2004 Nov; 53(11):963-77. PubMed ID: 15146294 [TBL] [Abstract][Full Text] [Related]
8. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions. Wells JW; Darling D; Farzaneh F; Galea-Lauri J Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742 [TBL] [Abstract][Full Text] [Related]
9. Immortalized dendritic cell line with efficient cross-priming ability established from transgenic mice harboring the temperature-sensitive SV40 large T-antigen gene. Ebihara S; Endo S; Ito K; Ito Y; Akiyama K; Obinata M; Takai T J Biochem; 2004 Sep; 136(3):321-8. PubMed ID: 15598888 [TBL] [Abstract][Full Text] [Related]
11. CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells: critical role in migration from the tumor site to draining lymph nodes. Hirao M; Onai N; Hiroishi K; Watkins SC; Matsushima K; Robbins PD; Lotze MT; Tahara H Cancer Res; 2000 Apr; 60(8):2209-17. PubMed ID: 10786686 [TBL] [Abstract][Full Text] [Related]
13. Comparison of DNA- and mRNA-transfected mouse dendritic cells as potential vaccines against the human papillomavirus type 16 associated oncoprotein E7. Dell K; Klein C; Gissmann L Antivir Ther; 2008; 13(4):495-509. PubMed ID: 18672528 [TBL] [Abstract][Full Text] [Related]
14. [In vitro inducing differentiation of bone marrow mononuclear cells of chronic myeloid leukemia]. Wu CY; Zhang LS; Zhang YF; Chai Y; Yi LC; Song FX Ai Zheng; 2005 Apr; 24(4):425-31. PubMed ID: 15820064 [TBL] [Abstract][Full Text] [Related]
15. CpG-ODN-stimulated dendritic cells act as a potent adjuvant for E7 protein delivery to induce antigen-specific antitumour immunity in a HPV 16 E7-associated animal tumour model. Kim TG; Kim CH; Won EH; Bae SM; Ahn WS; Park JB; Sin JI Immunology; 2004 May; 112(1):117-25. PubMed ID: 15096191 [TBL] [Abstract][Full Text] [Related]
16. [Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice]. Tan G; Wang ZY; Yin S Zhonghua Yi Xue Za Zhi; 2006 Apr; 86(14):943-6. PubMed ID: 16759530 [TBL] [Abstract][Full Text] [Related]
17. Therapeutic dendritic cell vaccination with Ag coupled to cholera toxin in combination with intratumoural CpG injection leads to complete tumour eradication in mice bearing HPV 16 expressing tumours. Chandy AG; Nurkkala M; Josefsson A; Eriksson K Vaccine; 2007 Aug; 25(32):6037-46. PubMed ID: 17629599 [TBL] [Abstract][Full Text] [Related]
18. Dendritic cells genetically engineered to simultaneously express endogenous tumor antigen and granulocyte macrophage colony-stimulating factor elicit potent therapeutic antitumor immunity. Nakamura M; Iwahashi M; Nakamori M; Ueda K; Matsuura I; Noguchi K; Yamaue H Clin Cancer Res; 2002 Aug; 8(8):2742-9. PubMed ID: 12171908 [TBL] [Abstract][Full Text] [Related]
19. [Enhanced translational efficacy of internal ribosomal entry site-mediated mRNA in dendritic cells contributes to efficient induction of antitumor immunity]. Tan XH; Wan YH Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(6):399-403. PubMed ID: 17456382 [TBL] [Abstract][Full Text] [Related]
20. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11. Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]